Brendon Colaco
Sleep Medicine · Jacksonville, FLNPI 1699901173
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,661 of the $13,890 with a category attached, or 84.0%. It is spread thinly across 27 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $4,105 and has fallen 51.0% since, to $2,010 in 2025.
Across 130 payments — averaging $106.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- ZOLL Respicardia, Inc.$2K
- Jazz Pharmaceuticals Inc.$2K
- AstraZeneca$2K
- Actelion Pharmaceuticals US, Inc.$691
- Boehringer Ingelheim$654
- plus $4K from 21 others
What the payments were for
- Travel & lodging$2,08415%
- Food & beverage$11,66184%
- Education$1451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 33 | $2,917 |
| ZOLL Respicardia, Inc. | 13 | $2,293 |
| Jazz Pharmaceuticals Inc. | 18 | $1,927 |
| AstraZeneca | 17 | $1,715 |
| Actelion Pharmaceuticals US, Inc. | 6 | $691 |
| Boehringer Ingelheim | 7 | $654 |
| Insmed, Inc. | 5 | $543 |
| United Therapeutics Corporation | 4 | $380 |
| GSK | 3 | $353 |
| Grifols USA, LLC | 2 | $252 |
| Axsome Therapeutics, Inc. | 2 | $243 |
| Novartis | 2 | $178 |
| Harmony Biosciences LLC | 3 | $175 |
| Sanofi | 2 | $159 |
| Ensodata, Inc. | 1 | $154 |
| Optinose US, Inc. | 1 | $135 |
| Mallinckrodt Hospital Products Inc. | 1 | $134 |
| Regeneron Healthcare Solutions, Inc. | 1 | $133 |
| Verona Pharma, Inc. | 1 | $125 |
| Mylan Specialty L.p. | 1 | $125 |
| Merck | 1 | $122 |
| Shionogi Inc | 1 | $122 |
| Medtronic | 1 | $113 |
| Idorsia Pharmaceuticals US Inc | 1 | $104 |
| Paratek Pharmaceuticals, Inc. | 1 | $86 |
| Pacira Pharmaceuticals Incorporated | 1 | $36 |
| Fisher & Paykel Healthcare Inc | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,890 in reported general payments places this provider in the 85th percentile of 77 sleep medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 24 | $318,147 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $8,042 |
| Atrovent HfaIpratropium Bromide | 11 | $5,055 |
| Advair DiskusFluticasone Propion/Salmeterol | 12 | $2,367 |
| Ropinirole Hcl | 11 | $137 |
| Zaleplon | 22 | $44 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev | $654 | $318,14724 claims |
| GSKBreo Ellipta | $353 | $8,04214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 77 sleep medicine providers in Florida.
Other sleep medicine in Jacksonville
- Joseph CheungJacksonville$12K
- Daniel ThielemannJacksonville$2K
- Nura FesticJacksonville$2K
- Gonzalo Labarca TruciosJacksonville$2K
- Loan leJacksonville$764
- Brynn DredlaJacksonville$708
- Jeremy McConnellBradenton$615K
- Edward MezerhaneMiami$537K
- Shane DrahosWinter Garden$317K
- Kunal AgarwalSarasota$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.